Peer Review reports
From: Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
| Original Submission | ||
|---|---|---|
| 7 Nov 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 12 Mar 2023 | Reviewed | Reviewer Report |
| 22 Mar 2023 | Reviewed | Reviewer Report |
| 5 Apr 2023 | Author responded | Author comments - Kyungmoo Yea |
| Resubmission - Version 4 | ||
| 5 Apr 2023 | Submitted | Manuscript version 4 |
| 10 Apr 2023 | Author responded | Author comments - Kyungmoo Yea |
| Resubmission - Version 5 | ||
| 10 Apr 2023 | Submitted | Manuscript version 5 |
| 4 May 2023 | Reviewed | Reviewer Report |
| 15 May 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 16 May 2023 | Editorially accepted | |
| 31 May 2023 | Article published | 10.1186/s12885-023-10975-3 |
You can find further information about peer review here.